Motus GI to go public with $25M IPO — 3 insights

Motus GI will sell 4.25 million shares of its common stock at $6 per share as it attempts to raise $25.5 million through a U.S.-based initial public offering, Seeking Alpha reports.

Here's what you should know:

1. Motus GI developed the Pure-Vu System, which assists with colonoscopy preparation.

2. Motus does not yet have a reimbursement code for the Pure-Vu system, and thus needs the public offering to raises funds for further clinical trials.

3. Motus will trade under the symbol MOTS.

More articles on gastroenterology: 
Physicians Endoscopy, Exact Sciences & more — 6 GI company key notes
How Anthem's new anesthesia policy for cataract surgery will affect ASCs — 5 insights
Dr. Brad Cohen replaces hip of celebrity chef Jeffrey Strauss — 4 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months